Summary
We have performed 23 estrogen and 24 progesterone receptor assays on tumor specimens from 26 patients with renal cancer, ten of whom subsequently received hormonal therapy for metastatic disease. Only one of these specimens contained measurable estrogen receptor levels, three contained low, but measurable progesterone receptor levels, and the remaining specimens contained no measurable estrogen or progesterone receptors. None of ten patients with metastases showed evidence of an objective response to hormonal therapy. Our data suggest that few, if any, renal cancers have high titers of estrogen or progesterone receptors, and that those patients whose tumors have low receptor titers are unlikely to respond to hormonal therapy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alberto P, Senn HJ (1974) Hormonal therapy of renal carcinoma alone and in association with cytostatic drugs. Cancer 33:1226–1229
Bloom HJG (1973) Hormone-induced and spontaneous regression of metastatic renal cancer. Cancer 32:1066–1071
Bojar H, Wittliff JL, Dreyfürst R, Boerminghauss F, Staib W (1975) Properties of specific estrogen-binding components in human kidney and renal carcinoma. (Abstract) Acta Endocrinol [Suppl] (Kbh) 193:51
Bojar H, Maar K, Staib W (1979) The endocrine background of human renal cell carcinoma. I. Binding of the highly potent progestin R 5020 by tumour cytosol. Urol Int 34:302–311
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
Concolino G, Marocchi A, Conti C, Tenaglia R, DiSilverio F, Bracci U (1978) Human renal cell carcinoma as a hormone-dependent tumor. Cancer Res 38:4340–4344
Concolino G, DiSilverio F, Marocchi A, Bracci U (1979) Renal cancer steroid receptors: Biochemical basis for endocrine therapy. Eur Urol 5:90–93
Hoffman PG, Jones LA, Kuhn RW, Sitteri PK (1980) Progesterone receptors: Saturation analysis by a solid phase hydroxyapatite absorption technique. Cancer 46:2801–2804
Jensen EV, Polley TZ, Smith S, Block GE, Ferguson DJ, DeSombre ER (1975) Prediction of hormone dependency in human breast cancer. In: McGuire WL, Carbone PP, Volmer EP (eds) Estrogen receptors in human breast cancer. Raven Press, New York, pp 37–56
Kirkman H (1959) Estrogen-induced tumors of the kidney. III. Growth characteristics in the Syrian hamster. Natl Cancer Inst Monogr 1:1–37
Li JJ, Talley DJ, Li SA, Vilee CA (1976) Receptor characteristics of specific estrogen binding in the renal adenocarcinoma of the golden hamster. Cancer Res 36:1127–1132
Li SA, Li JJ, Vilee CA (1977) Significance of the progesterone receptor in the estrogen-induced and-dependent renal tumor of the Syrian golden hamster. Ann NY Acad Sci 286:369–383
McGuire WL (1975) Current status of estrogen receptors in human breast cancer. Cancer 36:638–644
Morales A, Kiruluta G, Lott S (1975) Hormones in the treatment of metastatic renal cancer. J Urol 114:692–693
Rodbard D, Feldman HA (1975) Theory of protein-ligand interaction. Methods Enzymol 36:3–16
Seematter RJ, Hoffman PG, Kuhn RW, Lockwood LC, Siiteri PK (1978) Comparison of 3H progesterone and 6,7-3H-17, 21-dimethyl-19-norpregna-4, 9-diene-3, 20-dione for the measurement of progesterone receptors in human malignant tissue. Cancer Res 38:2800–2806
Siiteri PK (1963) The isolation of urinary estrogens and determination of their specific activities following the administration of radioactive precursors to humans. Steroids 2:687–712
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pearson, J., Friedman, M.A. & Hoffman, P.G. Hormone receptors in renal cell carcinoma. Cancer Chemother. Pharmacol. 6, 151–154 (1981). https://doi.org/10.1007/BF00262335
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00262335